Case involving senior dosimetrist at a premier cancer hospital in the Northeast suggests potential relevance of Phyto-N in one of oncology’s most serious and underserved supportive-care markets The ...
According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle ...
New research from the University of Oklahoma, published today in Cancer Cell, describes for the first time a "triangle regulation theory" of cancer-induced cachexia and anorexia. Cachexia is a ...
Clinical outcomes of gabapentinoids for oncologic pruritus: A retrospective cohort study. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not include a full ...
According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a ...
Cancer cachexia is a complex metabolic syndrome characterized by the ongoing loss of skeletal muscle mass, with or without fat loss, that cannot be reversed entirely by conventional nutritional ...
Immune checkpoint inhibitors (ICIs), including antibodies against the programmed cell death protein 1/ligand 1 (PD-1/L1) effectively at boost the immune system; however, they may cause immune-related ...
Cancer cachexia is a prevalent condition in pancreatic cancer (PC), affecting up to 80% of patients. There is an urgent need to understand this syndrome and identify potential targetable therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results